SCHEMBL18800768

SCHEMBL18800768

CS(=O)(=O)NCc1ccc(-c2ncc(-c3ccc(Oc4ccccc4)cc3)c(C(=N)N)c2N)cc1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 6/20 0.45
▸ SCN9A Q15858 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ LMNA P02545 1/20 0.36
▸ POLB P06746 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ RECQL P46063 1/20 0.36
▸ OPRM1 P35372 3/20 0.36
▸ OPRD1 P41143 3/20 0.36
▸ OPRK1 P41145 3/20 0.36
▸ TPH1 P17752 1/20 0.35
▸ PTGS2 P35354 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ ADAMTS4 O75173 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16168176 0.91 BTK (0.46) BTKSCN9A
SCHEMBL18800883 0.86 MAPK14 (0.40) BTKSCN9ASMN1; SMN2LMNAOPRM1
SCHEMBL18800565 0.86 BTK (0.61) BTKNPC1RAB9ASMN1; SMN2
SCHEMBL18800771 0.85 BTK (0.39) BTKOPRM1OPRD1OPRK1
SCHEMBL18800753 0.84 BTK (0.49) BTKSCN9A
SCHEMBL18800492 0.83 BTK (0.48) BTKSCN9A
SCHEMBL18800616 0.82 BTK (0.47) BTKSCN9A
SCHEMBL18800747 0.81 KMT2A (0.46) BTKNPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL18800564 0.81 BTK (0.47) BTKSCN9ANPC1RAB9ALMNA
SCHEMBL18800751 0.79 BTK (0.46) BTKPTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2789615-B1 Azaindazoles as Btk kinase modulators and use thereof BRISTOL MYERS SQUIBB CO (US) 2017-05-03 — — EP disclosed
Send feedback